Evidence map›Paper›PMID 26905426›Full record

ArticleScience signaling2016

Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis.

Brian J DeBosch, Monique R Heitmeier, Allyson L Mayer, Cassandra B Higgins, Jan R Crowley, Thomas E Kraft, Maggie Chi, Elizabeth P Newberry, Zhouji Chen, Brian N Finck and 4 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
26.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 273 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trehalose's untapped mechanisms in alzheimer's: gut-brain-autophagy signalling beyond the usual targets.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Brian J DeBoschDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA. debosch_b@kids.wustl.edu.
Monique R HeitmeierDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Allyson L MayerDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cassandra B HigginsDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jan R CrowleyDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Thomas E KraftDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Maggie ChiDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Elizabeth P NewberryDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Zhouji ChenDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Brian N FinckDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Nicholas O DavidsonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kevin E YarasheskiDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Paul W HruzDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kelle H MoleyDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Washington University in St. Louis · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Child Health Research CenterK12HD076224 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2013 to 2026
$6.2M
HEPATIC SYNTHESIS AND SECRETION OF APOLIPOPROTEIN (A)R01DK056260 · NIDDK · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 1999 to 2017
$5.9M
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS.R37HL038180 · NHLBI · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 2000 to 2009
$5.1M
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESISR01HL038180 · NHLBI · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 1986 to 2018
$3.8M
LIPIN 1 IN THE REGULATION OF HEPATIC LIPID METABOLISMR01DK078187 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2008 to 2016
$2.8M
NHLBI NIH HHS HL-38180NHLBI NIH HHS R01 HL038180NHLBI NIH HHS R37 HL038180NICHD NIH HHS K12 HD000850NICHD NIH HHS K12HD000850-29NICHD NIH HHS K12 HD076224NICHD NIH HHS K12HD076224NIDDK NIH HHS DK-56260NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30DK056341NIDDK NIH HHS P30DK52574NIDDK NIH HHS P60 DK020579NIDDK NIH HHS R01 DK056260NIDDK NIH HHS R01 DK078187NIDDK NIH HHS R01-DK078187NIGMS NIH HHS P41 GM103422NIGMS NIH HHS T32 GM007067NIGMS NIH HHS T32GM007067
6 · The paper itself

Abstract

Trehalose is a naturally occurring disaccharide that has gained attention for its ability to induce cellular autophagy and mitigate diseases related to pathological protein aggregation. Despite decades of ubiquitous use as a nutraceutical, preservative, and humectant, its mechanism of action remains elusive. We showed that trehalose inhibited members of the SLC2A (also known as GLUT) family of glucose transporters. Trehalose-mediated inhibition of glucose transport induced AMPK (adenosine 5'-monophosphate-activated protein kinase)-dependent autophagy and regression of hepatic steatosis in vivo and a reduction in the accumulation of lipid droplets in primary murine hepatocyte cultures. Our data indicated that trehalose triggers beneficial cellular autophagy by inhibiting glucose transport.

Indexed as

AutophagyAMP-Activated Protein KinasesAnimalsFatty LiverGlucose Transport Proteins, FacilitativeHEK293 CellsHep G2 CellsHumansMiceMice, KnockoutTrehaloseAMP-Activated Protein KinasesGlucose Transport Proteins, FacilitativeTrehalose

Identifiers

PMID26905426
PMCPMC4816640
OpenAlexW2286285703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.